Global Retirement Partners’s Rapport Therapeutics RAPP Stock Holding History
Bought
Maintained
Sold
Other funds holding RAPP
Global Retirement Partners's RAPP Position: Q3 2026 in Review
Global Retirement Partners held its Rapport Therapeutics (RAPP) position steady in Q3 2026 at 2 shares worth $67. The position accounts for ﹤0.01% of the portfolio, ranked #4819.
Global Retirement Partners first reported a position in RAPP in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.34K in Q3 2025. 169 funds tracked by Wall St. Rank hold RAPP as of Q3 2026.
- Global Retirement Partners held 2 shares of Rapport Therapeutics worth $67 as of Q3 2026.
- Global Retirement Partners left its Rapport Therapeutics share count unchanged in Q3 2026.
- Rapport Therapeutics made up ﹤0.01% of Global Retirement Partners's portfolio in Q3 2026, its #4819 holding.
- Global Retirement Partners first reported a position in Rapport Therapeutics in Q3 2025 and has held it in 4 quarters since.
- Global Retirement Partners's Rapport Therapeutics position peaked at $1.34K in Q3 2025.
- 169 funds tracked by Wall St. Rank held Rapport Therapeutics as of Q3 2026.
Based on Global Retirement Partners's 13F filing for Q3 2026, filed 10 Nov 2026.